Annotated Medicine and Device Lists


Octreotide

This medicine is present in:

List Section Observation
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. No observations
Mexico. Cuadro Basico de Medicamentos - 2017 05. ENDOCRINOLOGIA Y METABOLISMO No observations
Barbados. Barbados National Drug Formulary (BNDF) 68.29.04 Somatostatin Agonists No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Peptides No observations

This medicine is present in:

List Section Observation
Suriname. NGK-C-011 29.2 Other Special Essential Medicines No observations
Belize. National Drug Formulary 08.03 Hormones and antihormones No observations

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Peptides No observations

This medicine is present in:

List Section Observation
Guyana. Essential Medicines List. 2020-2021 19.11. Hypothalamic Hormone Analogue No observations
Belize. National Drug Formulary 08.03 Hormones and antihormones No observations

This medicine is present in:

List Section Observation
Barbados. Barbados National Drug Formulary (BNDF) 68.29.04 Somatostatin Agonists No observations

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 18.02. TRATAMIENTO HORMONAL DEL CÁNCER No observations

This medicine is present in:

List Section Observation
Costa Rica. Caja Costarricense de Seguro Social. 2019 32. Agentes gastrointestinales, antiácidos y antagonistas del receptor H2 No observations
Mexico. Cuadro Basico de Medicamentos - 2017 08. GASTROENTEROLOGIA No observations

This medicine is present in:

List Section Observation
Costa Rica. Caja Costarricense de Seguro Social. 2019 32. Agentes gastrointestinales, antiácidos y antagonistas del receptor H2 No observations

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 H. PREPARAÇÕES HORMONAIS SISTÊMICAS, EXCLUINDO HORMÔNIOS SEXUAIS E INSULINAS No observations

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 H. PREPARAÇÕES HORMONAIS SISTÊMICAS, EXCLUINDO HORMÔNIOS SEXUAIS E INSULINAS No observations

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 H. PREPARAÇÕES HORMONAIS SISTÊMICAS, EXCLUINDO HORMÔNIOS SEXUAIS E INSULINAS No observations

This medicine is present in:

List Section Observation
Costa Rica. Caja Costarricense de Seguro Social. 2019 32. Agentes gastrointestinales, antiácidos y antagonistas del receptor H2 No observations
Mexico. Cuadro Basico de Medicamentos - 2017 08. GASTROENTEROLOGIA No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 H. PREPARAÇÕES HORMONAIS SISTÊMICAS, EXCLUINDO HORMÔNIOS SEXUAIS E INSULINAS No observations
El Salvador - 2019 HORMONAS HIPOFISIARIAS E HIPOTALÁMICAS Y SUS ANÁLOGOS No observations
Belize. National Drug Formulary 08.03 Hormones and antihormones No observations

Information Resources: Octreotide

Loading ...
Loading ...
Loading ...
No information available